Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
James A Kaye Boston Collaborative Drug Surveillance Program,
Boston University School of Medicine, 11 Muzzey Street, Lexington,
MA 02421, USA
Correspondence to: J A Kaye jkaye{at}narsil.com
Objective:
To estimate changes in the risk of autism and assess the relation of autism to the mumps, measles, and rubella (MMR) vaccine.
Design:
Time trend analysis of data from the UK
general practice research database (GPRD).
Setting:
General practices in the United Kingdom.
Subjects:
Children aged 12 years or younger diagnosed with autism 1988-99, with further analysis of boys aged 2 to 5 years
born 1988-93.
Main outcome measures:
Annual and age specific
incidence for first recorded diagnoses of autism (that is, when the
diagnosis of autism was first recorded) in the children aged 12 years
or younger; annual, birth cohort specific risk of autism diagnosed in
the 2 to 5 year old boys; coverage (prevalence) of MMR vaccination in
the same birth cohorts.
Results:
The incidence of newly diagnosed autism
increased sevenfold, from 0.3 per 10 000 person years in 1988 to 2.1 per 10 000 person years in 1999. The peak incidence was among 3 and 4 year olds, and 83% (254/305) of cases were boys. In an annual birth
cohort analysis of 114 boys born in 1988-93, the risk of autism in 2 to
5 year old boys increased nearly fourfold over time, from 8 (95%
confidence interval 4 to 14) per 10 000 for boys born in 1988 to 29 (20 to 43) per 10 000 for boys born in 1993. For the same annual birth
cohorts the prevalence of MMR vaccination was over 95%.
Conclusions:
Because the incidence of autism among 2 to 5 year olds increased markedly among boys born in each year
separately from 1988 to 1993 while MMR vaccine coverage was over 95%
for successive annual birth cohorts, the data provide evidence that no
correlation exists between the prevalence of MMR vaccination and the
rapid increase in the risk of autism over time. The explanation for the
marked increase in risk of the diagnosis of autism in the past decade
remains uncertain.
© BMJ 2001
Read all Rapid Responses